Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

MRI characteristics of early PML-IRIS after natalizumab treatment in patients with MS.
Is the treatment of multiple sclerosis headed in the wrong direction?
Long-term Analyses of Innervation and Neuromuscular Integrity in the Trembler-J Mouse Model of Charcot-Marie-Tooth Disease.
Integrin/Chemokine Receptor Interactions in the Pathogenesis of Experimental Autoimmune Encephalomyelitis.
Simvastatin regulates oligodendroglial process dynamics and survival.
A combination trial of estriol plus glatiramer acetate in relapsing-remitting multiple sclerosis: effect on disabilities
Fingolimod treatment promotes regulatory phenotype and function of B cells.
Balance exercise for persons with multiple sclerosis using Wii games: a randomised, controlled multi-centre study.
Long term benefit of multiple sclerosis treatment: an investigation using a novel data collection technique.
A corrected version of the Timed-25 Foot Walk Test with a dynamic start to capture the maximum ambulation speed in multiple sclerosis patients.
Spasticity: pathophysiology, evaluation and management.
[Optic neuropathy and meningioma: A diagnostic trap.]
Cross Cultural Validation of The Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS) and The Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS).
The Alice in Wonderland syndrome: an unusual in acute disseminated encephalomyelitis.
Modulation of CNS autoimmune responses by CD8(+) T cells coincides with their oligoclonal expansion.
Interleukin-17- and interleukin-22-secreting myelin-specific CD4(+) T cells resistant to corticoids are related with active brain lesions in multiple sclerosis patients.
Age-specific sex ratio of multiple sclerosis in the National Swedish MS Register (SMSreg).
Immunological and clinical consequences of splenectomy in a multiple sclerosis patient treated with natalizumab.
Information regarding Active Biotech's candidate drug laquinimod
Overlapping demyelinating syndromes and anti-NMDA receptor encephalitis.
Correction: quantitative detection of epstein-barr virus DNA in cerebrospinal fluid and blood samples of patients with relapsing-remitting multiple sclerosis.
Neuroaxonal regeneration is more pronounced in early multiple sclerosis than in traumatic brain injury lesions.
Journal Club: Intrathecal effects of daclizumab treatment of multiple sclerosis.
Cyclophosphamide in multiple sclerosis: scientific rationale, history and novel treatment paradigms.
Combination of cyclophosphamide and interferon-beta halts progression in patients with rapidly transitional multiple sclerosis.

Pages